This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ranzani, G. N. Articles by Amadori, D. Search for Related Content PubMed PubMed Citation Articles by Ranzani, G. N. Articles by Amadori, D.

Heterogeneous Protooncogene Amplification Correlates with Tumor Progression and Presence of Metastases in Gastric Cancer Patients¹

Department of Genetics and Microbiology, University of Pavia, Via S. Epifanio 14, 27100 Pavia [G. N. R., N. S. P., C. P.], and Department of Oncology, Morgagni-Pierantoni Hospital, 47100 Forli [A. S., A. V., M. M., D. A.], Italy

In order to evaluate the relevance of protooncogene alterations in gastric cancer and to specifically relate these alterations to types and stages of the neoplasia, we studied oncogenes of possible interest in gastric tumors with different clinical parameters. Fifty DNAs from primary gastric adenocarcinoma were analyzed, by the Southern blotting technique, for the presence of amplification or rearrangements of seven different protooncogenes: c-myc, c-erbB2, c-Ki-ras, c-Ha-ras, c-N-ras, hst, and c-mos. All the tumors analyzed were histologically classified and staged. Amplification of the following genes was found: c-myc (2 of 50), hst (3 of 50), c-erbB2 (3 of 50), and c-Ki-ras (5 of 50). The simultaneous amplification of hst (3 cases), c-myc (1 of 3), or c-Ki-ras (2 of 3) was observed. Analysis of DNAs from atrophic and metaplastic gastric mucosa (which can be regarded as preneoplastic lesions) of the 10 patients showing gene amplification demonstrated that this was limited to neoplastic cells. Considering protooncogene amplification in general (i.e., involving different genes and occurring to different degrees) and clinical parameters of tumors, we found a statistically significant association between amplification and both tumor progression and presence of metastases. Therefore, at least for the genes analyzed, amplification is a relatively infrequent phenomenon and represents a late event in the temporal development of gastric cancer.

¹ This work was supported by a grant from Istituto Oncologico Romagnolo, Forli, Italy (Research Program 87111.1).

² To whom requests for reprints should be addressed.

Received 3/20/90. Accepted 9/17/90.

This article has been cited by other articles:

				V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, J. Staub, M. Morrissey, E. Calhoun, A. Sen, K. Kalli, et al. Genetic Analysis of Early- versus Late-Stage Ovarian Tumors Cancer Res., August 1, 2001; 61(15): 5895 - 5904. [Abstract] [Full Text] [PDF]

				V. G. Gorgoulis, P. Zacharatos, G. Mariatos, T. Liloglou, S. Kokotas, N. Kastrinakis, A. Kotsinas, A. Athanasiou, P. Foukas, V. Zoumpourlis, et al. Deregulated Expression of c-mos in Non-Small Cell Lung Carcinomas: Relationship with p53 Status, Genomic Instability, and Tumor Kinetics Cancer Res., January 1, 2001; 61(2): 538 - 549. [Abstract] [Full Text]

				P. Schraml, J. Kononen, L. Bubendorf, H. Moch, H. Bissig, A. Nocito, M. J. Mihatsch, O.-P. Kallioniemi, and G. Sauter Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types Clin. Cancer Res., August 1, 1999; 5(8): 1966 - 1975. [Abstract] [Full Text] [PDF]

				J. P. Rodrigo, P. S. Lazo, S. Ramos, I. Alvarez, and C. Suarez MYC Amplification in Squamous Cell Carcinomas of the Head and Neck Arch Otolaryngol Head Neck Surg, May 1, 1996; 122(5): 504 - 507. [Abstract] [PDF]

				M. Gapany, Z. P. Pavelic, D. J. Kelley, L. Pavelic, S. R. Gapany, J. M. Craven, P. J. Stambrook, and J. L. Gluckman Immunohistochemical Detection of c-myc Protein in Head and Neck Tumors Arch Otolaryngol Head Neck Surg, March 1, 1994; 120(3): 255 - 259. [Abstract] [PDF]